SlideShare a Scribd company logo
1 of 38
Download to read offline
Slide 1
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Risk-Based CAPA
Slide 2
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Inputs to the CAPA Process
CAPA	is	the	heart	of	a	Quality	Management	System	
(QMS)	and	indicates	how	effective	the	QMS	is.
CAPA’s
Risk	Analysis
MAUDE
Clinicals
Effectiveness	P
Service
Mngt.	Review
Internal	Audits
VOC	Surveys
NCMR’s
Complaints
Validation
Slide 3
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Key Elements of CAPA Forms
• Provide	Enough	Room
• Date	Initiated
• Include	a	Cross-Reference
• CAPA	Source
• Description	of	Issue
• Investigator	Assigned	&	Target	Due	Date
• Investigation	of	Problem
• Containment
• Correction(s)
• Investigation	of	Root	Cause
• Corrective	Action	Plan	&	Target	Due	Date
• Preventive	Action	Plan	&	Target	Due	Date
• Actions	Implemented
• Plan	for	Verification	of	Effectiveness
• Effectiveness	Verification
• Signature	&	Closure	Date
“15 Tips for Creating an Effective CAPA Form”
http://bit.ly/CAPAForm
Slide 4
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Root Cause Analysis Tools
• 5	Why	Analysis
• Is	/	Is	Not	Analysis
• Fishbone	Diagrams
• Affinity	Diagrams
• Pareto	Analysis
Slide 5
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
5 Why Analysis
Why	are	tires	blowing	 out	at	
20,000	miles?
Why	are	side	walls	too	thin?
Why	are	calipers	out	of	
tolerance?
Why	did	calibration	technician	
use	incorrect	procedure?
Why		wasn’t	a	transition	plan	created	
when	HR	person	was	laid	off?
Not just 5 questions
beginning in “WHY”,
but each question must
lead to the next.
Slide 6
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Is / Is Not Analysis
• What?
– What	is	the	object/process	affected?
– What	exactly	is	wrong?
• Where?
– Where	do	you	see	the	problem?
– Where	on	the	object	does	the	problem	occur?
• When?
– When	did	the	problem	occur?
– When	in	the	process	flow	does	the	problem	occur?
• How?
– How	does	the	problem	occurrence	form	a	pattern?
– How	big	is	the	problem?
• Ask	the	opposite	questions	too
Slide 7
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Fishbone Diagrams
Materials
Manpower
Mother
Nature
Measurement
Machines Methods
Effect
6M’s
Slide 8
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Brainstorming…
Idea	1
Idea	2
Idea	3
Idea	4
Idea	5
Idea	6
Idea	7
Idea	8
Slide 9
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Affinity Diagrams
9
Idea	1 Idea	2Idea	3
Idea	4
Idea	5 Idea	6
Idea	7Idea	8
Category	1 Category	2 Category	3
Slide 10
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Pareto Analysis
Slide 11
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Why Risk-Based?
• 21	CFR	820	– 1	instance	of	the	word	“risk”
• ISO	9001:2008	– 3	instances	of	the	word	“risk”
• ISO	9001:2015	– 31	+	10	instances	of	the	word	“risk”
• ISO	13485:2003	– 4	instances	of	the	word	“risk”
• ISO	13485:2016	– 20	instances	of	the	word	“risk”
“13485	Plus”	is	a	guidance	document	that	was	published	
by	the	Canadian	Standards	Association	in	February	2006.	
I	have	been	recommending	it	over	all	other	guidance	
documents	for	quality	system	implementation	since	
2010.	It	mentions	the	word	“risk”	60	times.
http://bit.ly/13485Plus
Slide 12
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
14971 Plus - http://bit.ly/ShopCSA
Slide 13
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
14971 Plus =
Standard + Gap + Bonus Tools
Slide 14
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Bonus Tools in 14971 Plus
Slide 15
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Risk Management is a Process
4 – Risk Analysis
5	– Risk	Evaluation
6	– Risk	Control
7	– Residual	Risk
Acceptability
8	– Risk	Management
Report
9	– Production	&
Post-production	Info
Risk
Assessment
Risk
Management
Slide 16
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Risk is Filter & Prioritization Tool
Quality	
Issues
Quality	
Plan
Risk	
Analysis
Trend	
Analysis
Formal	
CAPA
We	use	a	risk-
based	approach
We	always	
initiate	a	CAPA	
“Death by CAPA”
Slide 17
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
If it happens 3x…
• “How	many	nonconformities	can	occur	before	a	
CAPA	should	be	opened?”
– There	is	no	“Rule	of	3”
http://medicaldeviceacademy.com/minimum-data-points/
Slide 18
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Mitigation vs. Control
• In	the	2007	version	of	ISO	14971,	the	term	
“mitigation”	was	removed.
• Mitigation	implies	elimination	of	risks,	while	
control	implies	reducing	and	monitoring	risks.
Slide 19
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Corrective Action (ISO 9001:2015)
• Clause	10.2	– Nonconformity	&	Corrective	Action
– 10.2.1	When	a	nonconformity	occurs,	including	those	arising	from	complaints,	the	
organization	shall:
a) react	to	the	nonconformity,	and	as	applicable:
1. take	action	to	control	and	correct	it;
2. deal	with	the	consequences;
b) evaluate	the	need	for	action	to	eliminate	the	cause(s)	of	the	nonconformity,	in	order	that	it	
does	not	recur	or	occur	elsewhere,	by:
1. reviewing	the	nonconformity;
2. determining	the	causes	of	the	nonconformity;
3. determining	if	similar	nonconformities	exist,	or	could	potentially	occur;
c) implement	any	action	needed;
d) review	the	effectiveness	of	any	corrective	action	taken;
e) make	changes	to	the	quality	management	system,	if	necessary.
Corrective	actions	shall	be	appropriate	to	the	effects	of	the	nonconformities	encountered.
NOTE	1	In	some	instances,	it	can	be	impossible	to	eliminate	the	cause	of	a	nonconformity.
NOTE	2	Corrective	action	can	reduce	the	likelihood	of	recurrence	to	an	acceptable	level.
– 10.2.2	The	organization	shall	retain	documented	information	as	evidence	of:
a) the	nature	of	the	nonconformities	and	any	subsequent	actions	taken;
b) the	results	of	any	corrective	action.
Slide 20
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Definition of Risk in ISO 9001
• ISO	9001:2015,	Clause	3.09	[Source:	ISO	DIS	9000:2014,	3.7.4] - effect	
of	uncertainty	on	an	expected	result
– Note	1	to	entry:	An	effect	is	a	deviation	from	the	expected	— positive	or	
negative
– Note	2	to	entry:	Uncertainty	is	the	state,	even	partial,	of	deficiency	of	
information	(3.50)	related	to,	understanding	or	knowledge	(3.53)	of,	an	
event,	its	consequence,	or	likelihood.
– Note	3	to	entry:	Risk	is	often	characterized	by	reference	to	potential	
“events”	(as	defined	in	ISO	Guide	73:209,	3.5.1.3)	and	“consequences”	(as	
defined	in	ISO	Guide	73:2009,	3.6.1.3),	or	a	combination	of	these.
– Note	4	to	entry:	Risk	is	often	expressed	in	terms	of	a	combination	of	the	
consequences	of	an	event	(including	changes	in	circumstances)	and	the	
associated	“likelihood”	(as	defined	in	ISO	Guide	73:2009,	3.6.1.1)	of	
occurrence.
– Note	5	to	entry:	The	term	“risk”	is	sometimes	used	when	there	is	only	the	
possibility	of	negative	consequences
Slide 21
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Preventive Actions in ISO 9001:2015
Annex	A.4	– Risk-based	Approach
“One	of	the	key	purposes	of	a	quality	management	
system	is	to	act	as	a	preventive	tool.	Consequently,	
this	International	Standard	does	not	have	a	
separate	clause	or	sub-clause	titled	'Preventive	
action’.	The	concept	of	preventive	action	is	
expressed	through	a	risk-based	approach	to	
formulating	quality	management	system	
requirements.”
Slide 22
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Corrective Action (ISO 13485:2016)
Clause	8.5.2	– The	organization	shall	take	action	to	eliminate	the	cause	of	
nonconformities	in	to	prevent	recurrence.	Corrective	actions	shall	be	appropriate	
to	the	effects	of	the	nonconformities	encountered.	The	organization	shall	
document	a	procedure	to	define	requirements	for:
a) reviewing	nonconformities	(including	complaints);
b) determining	the	causes	of	nonconformities;
c) evaluating	the	need	for	action	to	ensure	that	nonconformities	do	not	recur;
d) planning	and	documenting	action	needed	and	implementing	such	action	in	
a	timely	manner,	including,	as	appropriate,	updating	documentation;
e) verifying	that	the	corrective	action	does	not	adversely	affect	the	ability	to	
meet	applicable	regulatory	requirements	or	the	safety	and	performance	of	
the	medical	device;	and
f) reviewing	the	effectiveness	of	corrective	action	taken.
Records	of	the	results	of	any	investigation	and	action	taken	shall	be	maintained
Slide 23
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Preventive Action (ISO 13485:2016)
Clause	8.5.3	– The	organization	shall	determine	action	to	eliminate	the	causes	of	
potential	nonconformities	in	order	to	prevent	their	occurrence.	Preventive	
actions	shall	be	appropriate	to	the	effects	of	the	potential	problems.	The	
organization	shall	document	a	procedure	to	describe	requirements	for:
a) determining	potential	nonconformities	and	their	causes,
b) evaluating	the	need	for	action	to	prevent	occurrence	of	nonconformities,
c) planning	and	documenting	action	needed,	and	implementing	such	action	in	a	
timely	manner,	including,	as	appropriate,	updating	documentation,
d) verifying	that	the	action	does	not	adversely	affect	the	ability	to	meet	
applicable	regulatory	requirements	or	the	safety	and	performance	of	
products,	and
e) reviewing	the	effectiveness	of	the	preventive	action	taken,	as	appropriate.
Records	of	the	results	of	any	investigations	and	of	action	taken	shall	be	
maintained
Slide 24
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
21 CFR 820.100
a) Each	manufacturer	shall	establish	and	maintain	procedures	for	implementing	 corrective	and	preventive	
action.	The	procedures	shall	include	requirements	for:
1) Analyzing	processes,	work	operations,	concessions,	quality	audit	reports,	quality	records,	service	
records,	complaints,	returned	product,	and	other	sources	of	quality	data	to	identify	existing	and	
potential	causes	of	nonconforming	product,	or	other	quality	problems.	Appropriate	statistical	
methodology	shall	be	employed	where	necessary	to	detect	recurring	quality	problems;
2) Investigating	the	cause	of	nonconformities	relating	to	product,	processes,	and	the	quality	system;
3) Identifying	the	action(s)	needed	to	correct	and	prevent	recurrence	 of	nonconforming	product	and	
other	quality	problems;
4) Verifying	or	validating	the	corrective	and	preventive	action	to	ensure	that	such	action	is	effective	
and	does	not	adversely	affect	the	finished	device;
5) Implementing	and	recording	changes	in	methods	and	procedures	needed	to	correct	and	prevent	
identified	quality	problems;
6) Ensuring	that	information	related	to	quality	problems	or	nonconforming	product	is	disseminated	
to	those	directly	responsible	for	assuring	the	quality	of	such	product	or	the	prevention	of	such	
problems;	and
7) Submitting	relevant	information	on	identified	quality	problems,	as	well	as	corrective	 and	
preventive	actions,	for		management	review.
b) All	activities	 required	under	this	section,	and	their	results,	shall	be	documented.
Slide 25
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Containment & Correction
• 21	CFR	820.90	– Control	of	Nonconforming	
Product	(new	language	in	ISO	13485:2016,	
Clause	8.3.1)	– determine	the	need	for	
investigation	and	notification	of	responsible	
party
• Clause	8.3.2	– Actions	taken
• 21	CFR	806	– Recalls/Corrections	&	Removals	
(now	ISO	13485:2016,	Clause	8.3.3)
• Clause	8.3.4	– Rework	(review	the	potential	
adverse	effects	of	rework)
Slide 26
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Risk Controls
• Inspection	– 21	CFR	820.80
• Process	Validation	– 21	CFR	820.75
Slide 27
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
21 CFR 820.250
Statistical	Techniques
a) Where	appropriate,	each	manufacturer	shall	establish	
and	maintain	procedures	for	identifying	valid	statistical	
techniques	required	for	establishing,	controlling,	and	
verifying	the	acceptability	of	process	capability	and	
product	characteristics.
b) Sampling	plans,	when	used,	shall	be	written	and	based	
on	a	valid	statistical	rationale.	Each	manufacturer	shall	
establish	and	maintain	procedures	to	ensure	that	
sampling	methods	are	adequate	for	their	intended	use	
and	to	ensure	that	when	changes	occur	the	sampling	
plans	are	reviewed.	These	activities	shall	be	
documented.
Slide 28
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Quantitative Effectiveness Checks
Cpk =	0.837
Cpk =	2.50
Preventive	Action
Slide 29
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Definition of Risk in ISO 13485
• ISO	13485:2016,	Clause	3.17	[Source:	ISO	
14971:2007,	definition	2.16] – combination	of	
the	probability	of	occurrence	of	harm	and	the	
severity	of	that	harm
P1	&	P2	from	Annex	E	of	ISO	14971:2007
Slide 30
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Hazard vs. Harm
• ISO	14971,	Clause	2.3	– Hazard	is	a	“potential	
source	of	harm”
[ISO/IEC	Guide	51:1999,	definition	3.5]
• ISO	14971,	Clause	2.2	– Harm	is	a	“physical	
injury	or	damage	to	the	health	of	people,	or	
damage	to	property	or	the	environment”
[ISO/IEC	Guide	51:1999,	definition	3.3]
Slide 31
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Scoring CAPA Risks
Catastrophic Critical Serious Minor Negligible
5 4 3 2 1
Frequent 5 Unacceptable Unacceptable Unacceptable Unacceptable ALARP
Probable 4 Unacceptable Unacceptable Unacceptable ALARP ALARP
Occasional 3 Unacceptable Unacceptable ALARP ALARP ALARP
Remote 2 Unacceptable ALARP ALARP ALARP Acceptable
Improbable 1 ALARP ALARP ALARP Acceptable Acceptable
ALARP As Low as Reasonably Practicable
Rating
↓®
Severity
Slide 32
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Average Aging of CAPAs
Slide 33
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Risk	
Analysis
CAPA & Risk Management Tasks
CAPA
Opened
CAPA
Closed
CAPA	
Initiation
Root	Cause	
Analysis
Corrective	
Action	Plan
Implementation
Effectiveness	
Verification
Hazard
Identification
Risk Control
Option Analysis
Risk
Assessment
Risk Control
Effectiveness Verification
Risk
Management
Plan
Slide 34
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Process Types & Risk Controls
• Manual	Processes
• Semi-Automated	
Processes
• Automated	Processes
• Batch	Processes
• 100%	Inspection
• Sampling	Plans
• Automated	Inspection
• Process	Validation
Trend	Analysis	&	Statistical	Techniques
Slide 35
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Quality Management System Planning
ISO	13485:2016,	Clause	5.4.2
Top	management	shall	ensure	that:
a) the	planning	of	the	quality	management	system	is	carried	
out	in	order	to	meet	the	requirements	given	in	4.1,	as	well	as	
the	quality	objectives,	and
b) the	integrity	of	the	quality	management	system	is	
maintained	when	changes	to	the	quality	management	
system	are	planned	and	implemented.
NOTE:	Quality	management	system	planning	normally	includes	
identification	and	implementation	of	action	items	that	are	
intended	to	accomplish	quality	objectives,	monitoring	the	
progress	toward	completion	of	action	items,	and	revision	to	the	
planning	based	on	monitoring.
Slide 36
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Change Management Advice
• Training	Plan	– Competency	(ISO	13485:2016,	
Clause	6.2b)
• Monitoring	&	Measurement	Plan
– ISO	13485:2016,	Clause	8.2.4	– Internal	Audit
– ISO	13485:2016,	Clause	8.2.5	– Monitoring	&	
Measurement	of	Processes
• Update	your	Master	Validation	Plan	&	
Revalidation	Requirements
Slide 37
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Other Training
http://medicaldeviceacademy.com/webinars/
http://medicaldeviceacademy.com/Amsterdam-510k-workshop/
Slide 38
Rob Packard, President
www.MedicalDeviceAcademy.com
rob@13485cert.com
Rob	Packard
rob@13485cert.com
+1.802.281.4381
rob13485
Q & A
https://calendly.com/13485cert/15min

More Related Content

What's hot

2006 pfmea presentation
2006 pfmea presentation2006 pfmea presentation
2006 pfmea presentation
ilker kayar
 
CAPA, Root Cause Analysis and Risk Management
CAPA, Root Cause Analysis and Risk ManagementCAPA, Root Cause Analysis and Risk Management
CAPA, Root Cause Analysis and Risk Management
Joseph Tarsio
 
ADVANCED PRODUCT QUALITY
ADVANCED PRODUCT QUALITYADVANCED PRODUCT QUALITY
ADVANCED PRODUCT QUALITY
anish malan
 
Fmea presentation
Fmea presentationFmea presentation
Fmea presentation
Murat Terzi
 

What's hot (20)

Risk management using FMEA in pharma
Risk management using FMEA in pharmaRisk management using FMEA in pharma
Risk management using FMEA in pharma
 
Corrective Action & Preventive Action
Corrective Action & Preventive ActionCorrective Action & Preventive Action
Corrective Action & Preventive Action
 
Corrective and preventive action
Corrective  and preventive actionCorrective  and preventive action
Corrective and preventive action
 
2006 pfmea presentation
2006 pfmea presentation2006 pfmea presentation
2006 pfmea presentation
 
Iso 9001:2015 internal auditor Course
Iso 9001:2015  internal auditor Course Iso 9001:2015  internal auditor Course
Iso 9001:2015 internal auditor Course
 
CAPA, Root Cause Analysis and Risk Management
CAPA, Root Cause Analysis and Risk ManagementCAPA, Root Cause Analysis and Risk Management
CAPA, Root Cause Analysis and Risk Management
 
Corrective action preventive action (capa)
Corrective action preventive action (capa)Corrective action preventive action (capa)
Corrective action preventive action (capa)
 
Computer System Validation
Computer System ValidationComputer System Validation
Computer System Validation
 
ADVANCED PRODUCT QUALITY
ADVANCED PRODUCT QUALITYADVANCED PRODUCT QUALITY
ADVANCED PRODUCT QUALITY
 
Root Cause Analysis - How It Informs CAPA
Root Cause Analysis - How It Informs CAPARoot Cause Analysis - How It Informs CAPA
Root Cause Analysis - How It Informs CAPA
 
Corrective & Preventive Action
Corrective & Preventive Action Corrective & Preventive Action
Corrective & Preventive Action
 
Audit and Regulatory compliance
Audit and Regulatory complianceAudit and Regulatory compliance
Audit and Regulatory compliance
 
Process F.M.E.A
Process F.M.E.AProcess F.M.E.A
Process F.M.E.A
 
Fmea presentation
Fmea presentationFmea presentation
Fmea presentation
 
Quality Management System awareness for all
Quality Management System awareness for all Quality Management System awareness for all
Quality Management System awareness for all
 
CSV - Computer System Validation
CSV - Computer System Validation CSV - Computer System Validation
CSV - Computer System Validation
 
Capa presentation
Capa presentationCapa presentation
Capa presentation
 
Deviation and root cause analysis in Pharma
Deviation and root cause analysis in PharmaDeviation and root cause analysis in Pharma
Deviation and root cause analysis in Pharma
 
ISO 9001: 2015 QUALITY MANAGEMENT SYSTEMS
ISO 9001: 2015 QUALITY MANAGEMENT SYSTEMSISO 9001: 2015 QUALITY MANAGEMENT SYSTEMS
ISO 9001: 2015 QUALITY MANAGEMENT SYSTEMS
 
Basics of FDA GMP Training
Basics of FDA GMP TrainingBasics of FDA GMP Training
Basics of FDA GMP Training
 

Similar to How to Create a Risk-Based CAPA Process

Preparing for your next FDA Inspection D3.pptx
Preparing for your next FDA Inspection D3.pptxPreparing for your next FDA Inspection D3.pptx
Preparing for your next FDA Inspection D3.pptx
mmmmm624454
 

Similar to How to Create a Risk-Based CAPA Process (20)

Leveraging Siebel CTMS for Risk-Based Monitoring
Leveraging Siebel CTMS for Risk-Based MonitoringLeveraging Siebel CTMS for Risk-Based Monitoring
Leveraging Siebel CTMS for Risk-Based Monitoring
 
Preparing for your next FDA Inspection D3.pptx
Preparing for your next FDA Inspection D3.pptxPreparing for your next FDA Inspection D3.pptx
Preparing for your next FDA Inspection D3.pptx
 
LSSWB#04 DMAIC_Improvement_Essential.pdf
LSSWB#04 DMAIC_Improvement_Essential.pdfLSSWB#04 DMAIC_Improvement_Essential.pdf
LSSWB#04 DMAIC_Improvement_Essential.pdf
 
Clinical QbD Best Practices When Outsourcing
Clinical QbD Best Practices When OutsourcingClinical QbD Best Practices When Outsourcing
Clinical QbD Best Practices When Outsourcing
 
Basic risk management presentation 17th june 2015
Basic risk management presentation 17th june 2015Basic risk management presentation 17th june 2015
Basic risk management presentation 17th june 2015
 
RbM Webinar Slides- A Practical Guide for Getting Your RBM Program Up and Run...
RbM Webinar Slides- A Practical Guide for Getting Your RBM Program Up and Run...RbM Webinar Slides- A Practical Guide for Getting Your RBM Program Up and Run...
RbM Webinar Slides- A Practical Guide for Getting Your RBM Program Up and Run...
 
Quality by design for Pharmaceutical Industries: An introduction
Quality by design for Pharmaceutical Industries: An introductionQuality by design for Pharmaceutical Industries: An introduction
Quality by design for Pharmaceutical Industries: An introduction
 
There's no time to test, can you just automate it? by Anna Heiermann
There's no time to test, can you just automate it? by Anna HeiermannThere's no time to test, can you just automate it? by Anna Heiermann
There's no time to test, can you just automate it? by Anna Heiermann
 
Risk - ALL YOU NEED TO KNOW ABOUT PMI-RMP
Risk - ALL YOU NEED TO KNOW ABOUT PMI-RMPRisk - ALL YOU NEED TO KNOW ABOUT PMI-RMP
Risk - ALL YOU NEED TO KNOW ABOUT PMI-RMP
 
Root Cause Analysis | QualiTest Group
Root Cause Analysis | QualiTest GroupRoot Cause Analysis | QualiTest Group
Root Cause Analysis | QualiTest Group
 
Adopting the Quadratic Mean Process to Quantify the Qualitative Risk Analysis...
Adopting the Quadratic Mean Process to Quantify the Qualitative Risk Analysis...Adopting the Quadratic Mean Process to Quantify the Qualitative Risk Analysis...
Adopting the Quadratic Mean Process to Quantify the Qualitative Risk Analysis...
 
The Future Of Pipeline Risk Management
The Future Of Pipeline Risk ManagementThe Future Of Pipeline Risk Management
The Future Of Pipeline Risk Management
 
LibraryFile_151624_32.pdf
LibraryFile_151624_32.pdfLibraryFile_151624_32.pdf
LibraryFile_151624_32.pdf
 
APICS DC 2016, Gary S Lynch, The Risk Project, LLC
APICS DC 2016, Gary S Lynch, The Risk Project, LLCAPICS DC 2016, Gary S Lynch, The Risk Project, LLC
APICS DC 2016, Gary S Lynch, The Risk Project, LLC
 
Root Cause and Corrective Action (RCCA) Workshop
Root Cause and Corrective Action (RCCA) WorkshopRoot Cause and Corrective Action (RCCA) Workshop
Root Cause and Corrective Action (RCCA) Workshop
 
Leaning towards action rev a
Leaning towards action rev aLeaning towards action rev a
Leaning towards action rev a
 
QA Fest 2015. Владимир Примаков. Процесс нагрузочного тестирования и его план...
QA Fest 2015. Владимир Примаков. Процесс нагрузочного тестирования и его план...QA Fest 2015. Владимир Примаков. Процесс нагрузочного тестирования и его план...
QA Fest 2015. Владимир Примаков. Процесс нагрузочного тестирования и его план...
 
Risk Management
Risk Management Risk Management
Risk Management
 
Андрій Мудрий “Risk managemnt: Welcome to Risk World” Lviv Project Managemen...
 Андрій Мудрий “Risk managemnt: Welcome to Risk World” Lviv Project Managemen... Андрій Мудрий “Risk managemnt: Welcome to Risk World” Lviv Project Managemen...
Андрій Мудрий “Risk managemnt: Welcome to Risk World” Lviv Project Managemen...
 
Андрій Мудрий «Risk managemnt: Welcome to Risk World»
Андрій Мудрий «Risk managemnt: Welcome to Risk World»Андрій Мудрий «Risk managemnt: Welcome to Risk World»
Андрій Мудрий «Risk managemnt: Welcome to Risk World»
 

More from Greenlight Guru

More from Greenlight Guru (20)

The Compliance Concern: Challenges and Roadblocks for Ensuring Compliance in ...
The Compliance Concern: Challenges and Roadblocks for Ensuring Compliance in ...The Compliance Concern: Challenges and Roadblocks for Ensuring Compliance in ...
The Compliance Concern: Challenges and Roadblocks for Ensuring Compliance in ...
 
How Electronic Data Capture Is Transforming the MedTech Industry
How Electronic Data Capture Is Transforming the MedTech IndustryHow Electronic Data Capture Is Transforming the MedTech Industry
How Electronic Data Capture Is Transforming the MedTech Industry
 
The ROI of Shifting Mindset From Compliance to Quality
The ROI of Shifting Mindset From Compliance to QualityThe ROI of Shifting Mindset From Compliance to Quality
The ROI of Shifting Mindset From Compliance to Quality
 
Leveraging Modern Software Technologies: MedTech’s Best Kept Secret
Leveraging Modern Software Technologies: MedTech’s Best Kept SecretLeveraging Modern Software Technologies: MedTech’s Best Kept Secret
Leveraging Modern Software Technologies: MedTech’s Best Kept Secret
 
Behind the Stats: Expectations vs. Reality of Bringing a Device to Market
Behind the Stats: Expectations vs. Reality of Bringing a Device to MarketBehind the Stats: Expectations vs. Reality of Bringing a Device to Market
Behind the Stats: Expectations vs. Reality of Bringing a Device to Market
 
Common Misconceptions on Medical Device Risk & Design Controls
Common Misconceptions on Medical Device Risk & Design ControlsCommon Misconceptions on Medical Device Risk & Design Controls
Common Misconceptions on Medical Device Risk & Design Controls
 
QMSR Harmonization: The Future of FDA's Quality Management System Regulation
QMSR Harmonization: The Future of FDA's Quality Management System RegulationQMSR Harmonization: The Future of FDA's Quality Management System Regulation
QMSR Harmonization: The Future of FDA's Quality Management System Regulation
 
QMS from a Regulatory Perspective
QMS from a Regulatory PerspectiveQMS from a Regulatory Perspective
QMS from a Regulatory Perspective
 
Modernizing your QMS to keep up with the Modern Age of Requirements
Modernizing your QMS to keep up with the Modern Age of RequirementsModernizing your QMS to keep up with the Modern Age of Requirements
Modernizing your QMS to keep up with the Modern Age of Requirements
 
eMDR Program and Process
eMDR Program and ProcesseMDR Program and Process
eMDR Program and Process
 
Moving up to the State of the Art in Risk Management
Moving up to the State of the Art in Risk ManagementMoving up to the State of the Art in Risk Management
Moving up to the State of the Art in Risk Management
 
ISO 13485: What's Next?
ISO 13485: What's Next?ISO 13485: What's Next?
ISO 13485: What's Next?
 
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceComputer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
 
Making Headway Despite the Turbulence: Regulatory Requirements, Quality, and ...
Making Headway Despite the Turbulence: Regulatory Requirements, Quality, and ...Making Headway Despite the Turbulence: Regulatory Requirements, Quality, and ...
Making Headway Despite the Turbulence: Regulatory Requirements, Quality, and ...
 
Reducing Friction Between Companies and Regulatory Bodies
Reducing Friction Between Companies and Regulatory BodiesReducing Friction Between Companies and Regulatory Bodies
Reducing Friction Between Companies and Regulatory Bodies
 
Latin American Regulations - What you Don't Know
Latin American Regulations - What you Don't KnowLatin American Regulations - What you Don't Know
Latin American Regulations - What you Don't Know
 
Insights on the MedTech Regulatory and Clinical Environment in Israel
Insights on the MedTech Regulatory and Clinical Environment in IsraelInsights on the MedTech Regulatory and Clinical Environment in Israel
Insights on the MedTech Regulatory and Clinical Environment in Israel
 
The Global Guide to Human Factors and Usability Engineering Regulations
The Global Guide to Human Factors and Usability Engineering RegulationsThe Global Guide to Human Factors and Usability Engineering Regulations
The Global Guide to Human Factors and Usability Engineering Regulations
 
MDSAP Certification: Success and Failures
MDSAP Certification: Success and FailuresMDSAP Certification: Success and Failures
MDSAP Certification: Success and Failures
 
QMSR Harmonization - The Good the Bad and the Ugly
QMSR Harmonization - The Good the Bad and the UglyQMSR Harmonization - The Good the Bad and the Ugly
QMSR Harmonization - The Good the Bad and the Ugly
 

Recently uploaded

obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
yulianti213969
 
Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...
DUBAI (+971)581248768 BUY ABORTION PILLS IN ABU dhabi...Qatar
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
vineshkumarsajnani12
 

Recently uploaded (20)

Top Quality adbb 5cl-a-d-b Best precursor raw material
Top Quality adbb 5cl-a-d-b Best precursor raw materialTop Quality adbb 5cl-a-d-b Best precursor raw material
Top Quality adbb 5cl-a-d-b Best precursor raw material
 
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDEUJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered  Building Manufacturers Hyderabad.pptxPre Engineered  Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptx
 
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptxGoal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
Goal Presentation_NEW EMPLOYEE_NETAPS FOUNDATION.pptx
 
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
 
A DAY IN THE LIFE OF A SALESPERSON .pptx
A DAY IN THE LIFE OF A SALESPERSON .pptxA DAY IN THE LIFE OF A SALESPERSON .pptx
A DAY IN THE LIFE OF A SALESPERSON .pptx
 
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDE
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDEJIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDE
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDE
 
Home Furnishings Ecommerce Platform Short Pitch 2024
Home Furnishings Ecommerce Platform Short Pitch 2024Home Furnishings Ecommerce Platform Short Pitch 2024
Home Furnishings Ecommerce Platform Short Pitch 2024
 
Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...
 
PALWAL CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN PALWAL ESCORTS
PALWAL CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN PALWAL ESCORTSPALWAL CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN PALWAL ESCORTS
PALWAL CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN PALWAL ESCORTS
 
The Art of Decision-Making: Navigating Complexity and Uncertainty
The Art of Decision-Making: Navigating Complexity and UncertaintyThe Art of Decision-Making: Navigating Complexity and Uncertainty
The Art of Decision-Making: Navigating Complexity and Uncertainty
 
How does a bike-share company navigate speedy success? - Cyclistic
How does a bike-share company navigate speedy success? - CyclisticHow does a bike-share company navigate speedy success? - Cyclistic
How does a bike-share company navigate speedy success? - Cyclistic
 
Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptxThompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
 

How to Create a Risk-Based CAPA Process

  • 1. Slide 1 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Risk-Based CAPA
  • 2. Slide 2 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Inputs to the CAPA Process CAPA is the heart of a Quality Management System (QMS) and indicates how effective the QMS is. CAPA’s Risk Analysis MAUDE Clinicals Effectiveness P Service Mngt. Review Internal Audits VOC Surveys NCMR’s Complaints Validation
  • 3. Slide 3 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Key Elements of CAPA Forms • Provide Enough Room • Date Initiated • Include a Cross-Reference • CAPA Source • Description of Issue • Investigator Assigned & Target Due Date • Investigation of Problem • Containment • Correction(s) • Investigation of Root Cause • Corrective Action Plan & Target Due Date • Preventive Action Plan & Target Due Date • Actions Implemented • Plan for Verification of Effectiveness • Effectiveness Verification • Signature & Closure Date “15 Tips for Creating an Effective CAPA Form” http://bit.ly/CAPAForm
  • 4. Slide 4 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Root Cause Analysis Tools • 5 Why Analysis • Is / Is Not Analysis • Fishbone Diagrams • Affinity Diagrams • Pareto Analysis
  • 5. Slide 5 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com 5 Why Analysis Why are tires blowing out at 20,000 miles? Why are side walls too thin? Why are calipers out of tolerance? Why did calibration technician use incorrect procedure? Why wasn’t a transition plan created when HR person was laid off? Not just 5 questions beginning in “WHY”, but each question must lead to the next.
  • 6. Slide 6 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Is / Is Not Analysis • What? – What is the object/process affected? – What exactly is wrong? • Where? – Where do you see the problem? – Where on the object does the problem occur? • When? – When did the problem occur? – When in the process flow does the problem occur? • How? – How does the problem occurrence form a pattern? – How big is the problem? • Ask the opposite questions too
  • 7. Slide 7 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Fishbone Diagrams Materials Manpower Mother Nature Measurement Machines Methods Effect 6M’s
  • 8. Slide 8 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Brainstorming… Idea 1 Idea 2 Idea 3 Idea 4 Idea 5 Idea 6 Idea 7 Idea 8
  • 9. Slide 9 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Affinity Diagrams 9 Idea 1 Idea 2Idea 3 Idea 4 Idea 5 Idea 6 Idea 7Idea 8 Category 1 Category 2 Category 3
  • 10. Slide 10 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Pareto Analysis
  • 11. Slide 11 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Why Risk-Based? • 21 CFR 820 – 1 instance of the word “risk” • ISO 9001:2008 – 3 instances of the word “risk” • ISO 9001:2015 – 31 + 10 instances of the word “risk” • ISO 13485:2003 – 4 instances of the word “risk” • ISO 13485:2016 – 20 instances of the word “risk” “13485 Plus” is a guidance document that was published by the Canadian Standards Association in February 2006. I have been recommending it over all other guidance documents for quality system implementation since 2010. It mentions the word “risk” 60 times. http://bit.ly/13485Plus
  • 12. Slide 12 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com 14971 Plus - http://bit.ly/ShopCSA
  • 13. Slide 13 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com 14971 Plus = Standard + Gap + Bonus Tools
  • 14. Slide 14 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Bonus Tools in 14971 Plus
  • 15. Slide 15 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Risk Management is a Process 4 – Risk Analysis 5 – Risk Evaluation 6 – Risk Control 7 – Residual Risk Acceptability 8 – Risk Management Report 9 – Production & Post-production Info Risk Assessment Risk Management
  • 16. Slide 16 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Risk is Filter & Prioritization Tool Quality Issues Quality Plan Risk Analysis Trend Analysis Formal CAPA We use a risk- based approach We always initiate a CAPA “Death by CAPA”
  • 17. Slide 17 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com If it happens 3x… • “How many nonconformities can occur before a CAPA should be opened?” – There is no “Rule of 3” http://medicaldeviceacademy.com/minimum-data-points/
  • 18. Slide 18 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Mitigation vs. Control • In the 2007 version of ISO 14971, the term “mitigation” was removed. • Mitigation implies elimination of risks, while control implies reducing and monitoring risks.
  • 19. Slide 19 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Corrective Action (ISO 9001:2015) • Clause 10.2 – Nonconformity & Corrective Action – 10.2.1 When a nonconformity occurs, including those arising from complaints, the organization shall: a) react to the nonconformity, and as applicable: 1. take action to control and correct it; 2. deal with the consequences; b) evaluate the need for action to eliminate the cause(s) of the nonconformity, in order that it does not recur or occur elsewhere, by: 1. reviewing the nonconformity; 2. determining the causes of the nonconformity; 3. determining if similar nonconformities exist, or could potentially occur; c) implement any action needed; d) review the effectiveness of any corrective action taken; e) make changes to the quality management system, if necessary. Corrective actions shall be appropriate to the effects of the nonconformities encountered. NOTE 1 In some instances, it can be impossible to eliminate the cause of a nonconformity. NOTE 2 Corrective action can reduce the likelihood of recurrence to an acceptable level. – 10.2.2 The organization shall retain documented information as evidence of: a) the nature of the nonconformities and any subsequent actions taken; b) the results of any corrective action.
  • 20. Slide 20 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Definition of Risk in ISO 9001 • ISO 9001:2015, Clause 3.09 [Source: ISO DIS 9000:2014, 3.7.4] - effect of uncertainty on an expected result – Note 1 to entry: An effect is a deviation from the expected — positive or negative – Note 2 to entry: Uncertainty is the state, even partial, of deficiency of information (3.50) related to, understanding or knowledge (3.53) of, an event, its consequence, or likelihood. – Note 3 to entry: Risk is often characterized by reference to potential “events” (as defined in ISO Guide 73:209, 3.5.1.3) and “consequences” (as defined in ISO Guide 73:2009, 3.6.1.3), or a combination of these. – Note 4 to entry: Risk is often expressed in terms of a combination of the consequences of an event (including changes in circumstances) and the associated “likelihood” (as defined in ISO Guide 73:2009, 3.6.1.1) of occurrence. – Note 5 to entry: The term “risk” is sometimes used when there is only the possibility of negative consequences
  • 21. Slide 21 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Preventive Actions in ISO 9001:2015 Annex A.4 – Risk-based Approach “One of the key purposes of a quality management system is to act as a preventive tool. Consequently, this International Standard does not have a separate clause or sub-clause titled 'Preventive action’. The concept of preventive action is expressed through a risk-based approach to formulating quality management system requirements.”
  • 22. Slide 22 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Corrective Action (ISO 13485:2016) Clause 8.5.2 – The organization shall take action to eliminate the cause of nonconformities in to prevent recurrence. Corrective actions shall be appropriate to the effects of the nonconformities encountered. The organization shall document a procedure to define requirements for: a) reviewing nonconformities (including complaints); b) determining the causes of nonconformities; c) evaluating the need for action to ensure that nonconformities do not recur; d) planning and documenting action needed and implementing such action in a timely manner, including, as appropriate, updating documentation; e) verifying that the corrective action does not adversely affect the ability to meet applicable regulatory requirements or the safety and performance of the medical device; and f) reviewing the effectiveness of corrective action taken. Records of the results of any investigation and action taken shall be maintained
  • 23. Slide 23 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Preventive Action (ISO 13485:2016) Clause 8.5.3 – The organization shall determine action to eliminate the causes of potential nonconformities in order to prevent their occurrence. Preventive actions shall be appropriate to the effects of the potential problems. The organization shall document a procedure to describe requirements for: a) determining potential nonconformities and their causes, b) evaluating the need for action to prevent occurrence of nonconformities, c) planning and documenting action needed, and implementing such action in a timely manner, including, as appropriate, updating documentation, d) verifying that the action does not adversely affect the ability to meet applicable regulatory requirements or the safety and performance of products, and e) reviewing the effectiveness of the preventive action taken, as appropriate. Records of the results of any investigations and of action taken shall be maintained
  • 24. Slide 24 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com 21 CFR 820.100 a) Each manufacturer shall establish and maintain procedures for implementing corrective and preventive action. The procedures shall include requirements for: 1) Analyzing processes, work operations, concessions, quality audit reports, quality records, service records, complaints, returned product, and other sources of quality data to identify existing and potential causes of nonconforming product, or other quality problems. Appropriate statistical methodology shall be employed where necessary to detect recurring quality problems; 2) Investigating the cause of nonconformities relating to product, processes, and the quality system; 3) Identifying the action(s) needed to correct and prevent recurrence of nonconforming product and other quality problems; 4) Verifying or validating the corrective and preventive action to ensure that such action is effective and does not adversely affect the finished device; 5) Implementing and recording changes in methods and procedures needed to correct and prevent identified quality problems; 6) Ensuring that information related to quality problems or nonconforming product is disseminated to those directly responsible for assuring the quality of such product or the prevention of such problems; and 7) Submitting relevant information on identified quality problems, as well as corrective and preventive actions, for management review. b) All activities required under this section, and their results, shall be documented.
  • 25. Slide 25 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Containment & Correction • 21 CFR 820.90 – Control of Nonconforming Product (new language in ISO 13485:2016, Clause 8.3.1) – determine the need for investigation and notification of responsible party • Clause 8.3.2 – Actions taken • 21 CFR 806 – Recalls/Corrections & Removals (now ISO 13485:2016, Clause 8.3.3) • Clause 8.3.4 – Rework (review the potential adverse effects of rework)
  • 26. Slide 26 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Risk Controls • Inspection – 21 CFR 820.80 • Process Validation – 21 CFR 820.75
  • 27. Slide 27 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com 21 CFR 820.250 Statistical Techniques a) Where appropriate, each manufacturer shall establish and maintain procedures for identifying valid statistical techniques required for establishing, controlling, and verifying the acceptability of process capability and product characteristics. b) Sampling plans, when used, shall be written and based on a valid statistical rationale. Each manufacturer shall establish and maintain procedures to ensure that sampling methods are adequate for their intended use and to ensure that when changes occur the sampling plans are reviewed. These activities shall be documented.
  • 28. Slide 28 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Quantitative Effectiveness Checks Cpk = 0.837 Cpk = 2.50 Preventive Action
  • 29. Slide 29 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Definition of Risk in ISO 13485 • ISO 13485:2016, Clause 3.17 [Source: ISO 14971:2007, definition 2.16] – combination of the probability of occurrence of harm and the severity of that harm P1 & P2 from Annex E of ISO 14971:2007
  • 30. Slide 30 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Hazard vs. Harm • ISO 14971, Clause 2.3 – Hazard is a “potential source of harm” [ISO/IEC Guide 51:1999, definition 3.5] • ISO 14971, Clause 2.2 – Harm is a “physical injury or damage to the health of people, or damage to property or the environment” [ISO/IEC Guide 51:1999, definition 3.3]
  • 31. Slide 31 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Scoring CAPA Risks Catastrophic Critical Serious Minor Negligible 5 4 3 2 1 Frequent 5 Unacceptable Unacceptable Unacceptable Unacceptable ALARP Probable 4 Unacceptable Unacceptable Unacceptable ALARP ALARP Occasional 3 Unacceptable Unacceptable ALARP ALARP ALARP Remote 2 Unacceptable ALARP ALARP ALARP Acceptable Improbable 1 ALARP ALARP ALARP Acceptable Acceptable ALARP As Low as Reasonably Practicable Rating ↓® Severity
  • 32. Slide 32 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Average Aging of CAPAs
  • 33. Slide 33 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Risk Analysis CAPA & Risk Management Tasks CAPA Opened CAPA Closed CAPA Initiation Root Cause Analysis Corrective Action Plan Implementation Effectiveness Verification Hazard Identification Risk Control Option Analysis Risk Assessment Risk Control Effectiveness Verification Risk Management Plan
  • 34. Slide 34 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Process Types & Risk Controls • Manual Processes • Semi-Automated Processes • Automated Processes • Batch Processes • 100% Inspection • Sampling Plans • Automated Inspection • Process Validation Trend Analysis & Statistical Techniques
  • 35. Slide 35 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Quality Management System Planning ISO 13485:2016, Clause 5.4.2 Top management shall ensure that: a) the planning of the quality management system is carried out in order to meet the requirements given in 4.1, as well as the quality objectives, and b) the integrity of the quality management system is maintained when changes to the quality management system are planned and implemented. NOTE: Quality management system planning normally includes identification and implementation of action items that are intended to accomplish quality objectives, monitoring the progress toward completion of action items, and revision to the planning based on monitoring.
  • 36. Slide 36 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Change Management Advice • Training Plan – Competency (ISO 13485:2016, Clause 6.2b) • Monitoring & Measurement Plan – ISO 13485:2016, Clause 8.2.4 – Internal Audit – ISO 13485:2016, Clause 8.2.5 – Monitoring & Measurement of Processes • Update your Master Validation Plan & Revalidation Requirements
  • 37. Slide 37 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Other Training http://medicaldeviceacademy.com/webinars/ http://medicaldeviceacademy.com/Amsterdam-510k-workshop/
  • 38. Slide 38 Rob Packard, President www.MedicalDeviceAcademy.com rob@13485cert.com Rob Packard rob@13485cert.com +1.802.281.4381 rob13485 Q & A https://calendly.com/13485cert/15min